Tom J G Gevers Selected Research

1-dodecylpyridoxal (PLD)

1/2022	Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly.
1/2020	New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease.
12/2019	Estrogen-Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients.
6/2019	Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
6/2018	Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.
1/2018	Drug holiday in patients with polycystic liver disease treated with somatostatin analogues.
1/2016	Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.
11/2014	Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume.
8/2013	Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.
7/2013	Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tom J G Gevers Research Topics

Disease

16	Polycystic liver disease 01/2022 - 05/2011
9	Cysts 01/2020 - 05/2011
7	Autosomal Dominant Polycystic Kidney (ADPKD) 04/2016 - 05/2011
4	Autoimmune Hepatitis 04/2022 - 01/2019
3	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2020 - 05/2011
2	Hepatomegaly 01/2022 - 11/2014
2	Neoplasms (Cancer) 12/2018 - 01/2016
1	Umbilical Hernia (Omphalocele) 01/2022
1	Rare Diseases (Rare Disease) 01/2020
1	Weight Loss (Weight Reduction) 12/2018
1	Liver Cell Adenoma (Hepatocellular Adenoma) 12/2018
1	Ascites 01/2018
1	Chronic Disease (Chronic Diseases) 01/2018
1	Dyspnea (Shortness of Breath) 05/2015
1	Cystadenoma 06/2013
1	Echinococcosis (Hydatid Cysts) 06/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2013
1	Cystadenocarcinoma 06/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2012

Drug/Important Bio-Agent (IBA)

12	1-dodecylpyridoxal (PLD)IBA 01/2022 - 02/2013
8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2018 - 05/2011
3	lanreotide (Somatuline)FDA Link 04/2016 - 04/2012
2	Transaminases (Aminotransferases)IBA 04/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2012
2	Azathioprine (Imuran)FDA LinkGeneric 01/2020 - 01/2019
2	pasireotideIBA 06/2018 - 03/2015
2	Pharmaceutical PreparationsIBA 04/2016 - 04/2012
2	Octreotide (Sandostatin)FDA LinkGeneric 04/2016 - 07/2013
1	Immunoglobulin G (IgG)IBA 04/2022
1	SteroidsIBA 01/2020
1	Oral ContraceptivesIBA 12/2019
1	Estrogens (Estrogen)FDA Link 12/2019
1	DiureticsIBA 01/2018
1	Alkaline PhosphataseIBA 04/2016
1	Everolimus FDA Link 07/2013
1	Sirolimus (Rapamycin)FDA Link 07/2013
1	Fibroblast Growth Factor-23IBA 04/2012
1	MTOR InhibitorsIBA 05/2011

Therapy/Procedure

5	Therapeutics 01/2020 - 02/2013
5	Sclerotherapy 06/2019 - 03/2015
1	Aftercare (After-Treatment) 06/2019
1	Bariatric Surgery 12/2018
1	Microbubbles 06/2013